Trial intelligence / Profile preview

Aging and Estrogen Effect on Pituitary GnRH Response

NCT00386022Phase 3Unknown

Sponsor
Massachusetts General Hospital
Start
Jan 2002
Primary completion
Jan 2012
Countries
1
01

Overview

Phase 3, open-label trial of estradiol topical in postmenopause (2 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Pituitary Response to GnRH and Effect of Estrogen on Pituitary Response to GnRH. Status: unknown.

02

Drugs

estradiol topical
03

Conditions

postmenopause

Beyond the preview

Go deeper on NCT00386022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00386022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call